Rotigotine
6 NDCs across 1 manufacturer|0 Generic,6 Brand
Rotigotine is used to treat parkinson disease and restless legs syndrome, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 9, 2007. In 2024, Medicare Part D spent $90 million on Rotigotine across 78,000 claims for 15,000 beneficiaries.
Rotigotine is available as 6 NDCs from 1 manufacturer (0 generic, 6 brand), with NADAC prices from $28.18 to $28.32 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
0G / 6B
Manufacturers
1
competing in market
Price Spread
$28.18 – $28.32
per EA
7d Activity
avg -0.0% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
UCB, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Nonergot Dopamine Agonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing ROTIGOTINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
NEUPRO 4 MG/24 HR PATCH | $28.3161 per EA | -0.14% |
NEUPRO 1 MG/24 HR PATCH | $28.2868 per EA | +0.10% |
NEUPRO 2 MG/24 HR PATCH | $28.2602 per EA | -0.01% |
NEUPRO 3 MG/24 HR PATCH | $28.2504 per EA | +0.02% |
NEUPRO 8 MG/24 HR PATCH | $28.2416 per EA | -0.01% |
NEUPRO 6 MG/24 HR PATCH | $28.1788 per EA | -0.01% |
Frequently Asked Questions
What is Rotigotine used to treat?
Rotigotine is used to treat parkinson disease and restless legs syndrome, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Rotigotine?
In 2024, Medicare Part D spent $90 million on Rotigotine across 78,000 claims for 15,000 beneficiaries.
How many Rotigotine products are on the market?
The Rotigotine drug market contains 6 NDCs from 1 manufacturer — 0 generic and 6 brand products.
What is the price range for Rotigotine?
NADAC reference prices for Rotigotine range from $28.1788 to $28.3161 per EA — a 0% difference between cheapest and most expensive.
Which manufacturers make Rotigotine?
1 manufacturer lists Rotigotine in NADAC. Ranked by number of NDCs, the largest are UCB, Inc. (6).
How has the price of Rotigotine changed recently?
Over the past 7 days, 2 Rotigotine NDCs rose and 4 fell, with a market-wide average change of -0.0%.